Use of veno-venous extracorporeal membrane oxygenation in a female patient with severe acute respiratory distress syndrome and peri-intubation cardiac arrest. Clinical observation
https://doi.org/10.17650/2782-3202-2023-3-4-52-59
Abstract
Acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure which can occur in people of any age. It comprises about 10 % of all admissions in intensive care units. The cornerstone of treatment of severe forms of this disorder is protective mechanical ventilation but in patients with initial hypoxia and/or hypotension tracheal intubation is associated with the risk of significant hemodynamic abnormalities. Mortality from severe forms of ARDS remains high.
COVID-19 pandemic led to worldwide wider use of such techniques of respiratory support as high-flow nasal oxygen therapy and non-invasive ventilation, the necessity of which is proposed to be used as one of classifying signs of ARDS in addition to the Berlin criteria.
If the respiratory therapy is ineffective, veno-venous extracorporeal membrane oxygenation is used for gaseous exchange and decreasing undesirable effects of high pressure in the respiratory pathways. The success of its application strongly depends on the optimal timing of its initialization. The performance of this technique is associated with a number of complications (hemorrhage, thrombosis, sepsis, etc.). Effective treatment of ARDS requires utilization of a large amount of resources and educated staff.
About the Authors
A. V. OskolkovRussian Federation
Artem Vladimirovich Oskolkov
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
M. V. Antonets
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
P. M. Bagdasaryan
Russian Federation
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081
G. A. Ovsyannikov
Russian Federation
100a Lakhtinskiy Ave., St. Peterburg 197229
References
1. Bellani G., Laffey J.G., Pham T. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788–800. DOI: 10.1001/jama.2016.0291
2. Banavasi H., Nguyen P., Osman H., Soubani A.O. Management of ARDS – what works and what does not. Am J Med Sci 2021;362(1):13–23. DOI: 10.1016/j.amjms.2020.12.019
3. Matthay M.A., Arabi Y., Arroliga A.C. et al. A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med 2023. DOI: 10.1164/rccm.202303-0558WS
4. Demoule A., Hill N., Navalesi P. Can we prevent intubation in patients with ARDS? Intensive Care Med 2016;42(5):768–71. DOI: 10.1007/s00134-016-4323-6
5. Frat J.P., Thille A.W., Mercat A. et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–96. DOI: 10.1056/NEJMoa1503326
6. Kangelaris K.N., Ware L.B., Wang C.Y. et al. Timing of intubation and clinical outcomes in adults with acute respiratory distress syndrome. Crit Care Med 2016;44(1):120–9. DOI: 10.1097/CCM.0000000000001359
7. Bauer P.R., Kumbamu A., Wilson M.E. et al. Timing of intubation in acute respiratory failure associated with Sepsis: a mixed methods study. Mayo Clin Proc 2017;92(10):1502–10. DOI: 10.1016/j.mayocp.2017.07.001
8. Perbet S., De Jong A., Delmas J. et al. Incidence of and risk factors for severe cardiovascular collapse after endotracheal intubation in the ICU: a multicenter observational study. Crit Care 2015;19(1):257. DOI: 10.1186/s13054-015-0975-9
9. Russotto V., Myatra S.N., Laffey J.G. et al. Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries. JAMA 2021;325(12):1164–72. DOI: 10.1001/jama.2021.1727
10. Sameed M., Meng Z., Marciniak E.T. EOLIA trial: the future of extracorporeal membrane oxygenation in acute respiratory distress syndrome therapy? Breathe (Sheff) 2019;15(3):244–6. DOI: 10.1183/20734735.0363-2018
11. April M.D., Arana A., Reynolds J.C. et al. Peri-intubation cardiac arrest in the Emergency Department: a National Emergency Airway Registry (NEAR) study. Resuscitation 2021;162:403–11. DOI: 10.1016/j.resuscitation.2021.02.039
12. Sandroni C., D'Arrigo S., Nolan J.P. Prognostication after cardiac arrest. Crit Care 2018;22(1):150. DOI: 10.1186/s13054-018-2060-7
13. Sandroni C., D'Arrigo S., Cacciola S. et al. Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review. Intensive Care Med 2022;48(4):389–413. DOI: 10.1007/s00134-022-06618-z
14. Shrestha D.B., Sedhai Y.R., Budhathoki P. et al. Extracorporeal membrane oxygenation (ECMO) dependent acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis. Cureus 2022;14(6):e25696. DOI: 10.7759/cureus.25696
15. Grasselli G., Calfee C.S., Camporota L. et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 2023;49(7):727–59. DOI: 10.1007/s00134-023-07050-7
16. Weingart C., Lubnow M., Philipp A. et al. Comparison of coagulation parameters, anticoagulation, and need for transfusion in patients on interventional lung assist or veno-venous extracorporeal membrane oxygenation. Artif Organs 2015;39(9):765–73. DOI: 10.1111/aor.12464
17. Martucci G., Panarello G., Occhipinti G. et al. Anticoagulation and transfusions management in veno-venous extracorporeal membrane oxygenation for acute respiratory distress syndrome: assessment of factors associated with transfusion requirements and mortality. J Intensive Care Med 2019;34:630–9.
18. Dado D.N., Ainsworth C.R., Thomas S.B. et al. Outcomes among patients treated with renal replacement therapy during extracorporeal membrane oxygenation: a single-center retrospective study. Blood Purif 2020;49(3):341–7. DOI: 10.1159/000504287
19. Fleming G.M., Askenazi D.J., Bridges B.C. et al. A multicenter international survey of renal supportive therapy during ECMO: the Kidney Intervention During Extracorporeal Membrane Oxygenation (KIDMO) group. ASAIO J 2012;58(4):407–14. DOI: 10.1097/MAT.0b013e3182579218
20. Ostermann M., Connor M. Jr., Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation. Curr Opin Crit Care 2018;24(6):493–503. DOI: 10.1097/MCC.0000000000000559
21. Laverdure F., Masson L., Tachon G. et al. Connection of a renal replacement therapy or plasmapheresis device to the ECMO circuit. ASAIO J 2018;64(1):122–5. DOI: 10.1097/MAT.0000000000000621
22. Suga N., Matsumura Y., Abe R. et al. A safe procedure for connecting a continuous renal replacement therapy device into an extracorporeal membrane oxygenation circuit. J Artif Organs 2017;20(2):125–31. DOI: 10.1007/s10047-017-0952-y
23. Selewski D.T., Wille K.M. Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation. Semin Dial 2021;34(6):537–49. DOI: 10.1111/sdi.12965
24. Chen H., Yu R.G., Yin N.N., Zhou J.X. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit Care 2014;18(6):675. DOI: 10.1186/s13054-014-0675-x
25. Pickkers P., Vassiliou T., Liguts V. et al. Sepsis management with a blood purification membrane: European experience. Blood Purif 2019;47(Suppl 3):1–9. DOI: 10.1159/000499355
26. Zhang L., Feng Y., Fu P. Blood purification for sepsis: an overview. Precis Clin Med 2021;4(1):45–55. DOI: 10.1093/pcmedi/pbab005
27. Monard C., Rimmelé T., Ronco C. Extracorporeal blood purification therapies for sepsis. Blood Purif 2019;47(Suppl 3):1–14. DOI: 10.1159/000499520
28. Redant S., De Bels D., Honoré P.M. Rationale of blood purification in the post-resuscitation syndrome following out-of-hospital cardiac arrest: a narrative review. Blood Purif 2021;50(6):750–7. DOI: 10.1159/000510127
Review
For citations:
Oskolkov A.V., Antonets M.V., Bagdasaryan P.M., Ovsyannikov G.A. Use of veno-venous extracorporeal membrane oxygenation in a female patient with severe acute respiratory distress syndrome and peri-intubation cardiac arrest. Clinical observation. MD-Onco. 2023;3(4):52-59. (In Russ.) https://doi.org/10.17650/2782-3202-2023-3-4-52-59